Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288612 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts Esophagus
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 459
- Enrollment target
NCT01288612: Completed NA study, sponsored by Mayo Clinic.
NCT01288612 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 459 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01288612, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 459 participants
- Enrollment target
Study Summary
The hypothesis of this study was that the comparative effectiveness of unsedated transnasal endoscopy (uTNE) will be greater than sedated endoscopy (sEGD) in population screening for BE.
Interventions
- DEVICE Transnasal Endoscopy
- DEVICE Sedated Endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01288612
The ClinicalTrials.gov registry entry for NCT01288612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 459 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transnasal Endoscopy is the first listed.
NCT01288612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01288612 about?
NCT01288612 is a clinical study titled "Comparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts Esophagus". The hypothesis of this study was that the comparative effectiveness of unsedated transnasal endoscopy (uTNE) will be greater than sedated endoscopy (sEGD) in population screening for BE.
What is the current status of trial NCT01288612?
This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2011-02. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01288612?
The interventions under investigation include: Transnasal Endoscopy (DEVICE), Sedated Endoscopy (DEVICE).
Who is sponsoring clinical trial NCT01288612?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.